Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 July 2021 | Story André Damons | Photo Supplied
Mutshidzi Abigail Mulondo, Lecturer and PhD candidate in the Faculty of Health Sciences at the University of the Free State (UFS), has been recognised as one of the Mail & Guardian’s 200 Young South Africans.

For Mutshidzi Abigail Mulondo, Lecturer and PhD candidate in the Faculty of Health Sciences at the University of the Free State (UFS), being recognised as one of the Mail & Guardian 200 Young South Africans is encapsulated in Mark Twain’s quote, “The two most important days in your life are the day you are born and the day you find out why”.

Knowing that she is living her ‘why I was born’ and actually being recognised for it, is a wonderful feeling, says Mulondo, whose passion is public health.

“I feel honoured to have been considered and counted among influential young South Africans who are doing incredible work. I am thankful to Mail & Guardian for this wonderful recognition,” says Mulondo.

Passion and commitment to promoting health 

She was nominated by one of her mentors but was sceptical that she would be in the final 200 list, as there are usually more than 5 000 applications each year. According to Mulondo, she is happy to have been proven wrong and even more grateful to be surrounded by powerful women who continue to propel her towards her purpose.

Mulondo says she always knew that she wanted to be in a position to help alleviate pain and suffering and that health would be her avenue to serve humanity. Says Mulondo: “When I started with an interdisciplinary PhD in Health Professions Education and Community Health, it further solidified my passion and commitment to promoting health.”
“I am equally passionate about mental health wellness. After completing a master’s degree in Psychology at the University of Pretoria, I knew it would provide me with an opportunity to impact people’s lives more holistically. An opportunity to not only promote physical health, but to also advocate for mental health.”

Hope for the youth of South Africa

Mulondo’s message to young people is also the motto she lives by: “Be kinder to yourself”. So many times, we are hard on ourselves when we fail or when we do not accomplish what we set out to accomplish at a particular time. 

“Please remember that you are the only you that will ever be. You must therefore be gentler with yourself; despite what you thought you would have achieved thus far, appreciate how far you have actually come against whatever odds,” says Mulondo.

Her hope for the youth of South Africa is that we reach a point where fighting against issues such as gender-based violence (GBV), systematic racism, gender inequality, high unemployment rates, and all other constructs that affect our youth and country is a matter of the past. “While we envision that day, I hope that we all continue to stand together and speak up for the vulnerable, marginalised, and disenfranchised. I am confident that we will see and experience the fullest potential of our youth, in this lifetime (Jeremiah 29:11).”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept